EP2015803A4 - Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances - Google Patents

Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Info

Publication number
EP2015803A4
EP2015803A4 EP07835752A EP07835752A EP2015803A4 EP 2015803 A4 EP2015803 A4 EP 2015803A4 EP 07835752 A EP07835752 A EP 07835752A EP 07835752 A EP07835752 A EP 07835752A EP 2015803 A4 EP2015803 A4 EP 2015803A4
Authority
EP
European Patent Office
Prior art keywords
asperities
sequestering
carrying
nanofiber structures
transferring substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07835752A
Other languages
German (de)
English (en)
Other versions
EP2015803A2 (fr
Inventor
Darrell H Reneker
Daniel J Smith
David Barrett Meyers
Nevenka Golubovic-Liakopoulos
Alexander Marin
Alexander K Andrianov
Peter G Carroll
Sanford R Simon
Tao Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Akron
Apogee Technology Inc
Original Assignee
University of Akron
Apogee Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Akron, Apogee Technology Inc filed Critical University of Akron
Publication of EP2015803A2 publication Critical patent/EP2015803A2/fr
Publication of EP2015803A4 publication Critical patent/EP2015803A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
EP07835752A 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances Withdrawn EP2015803A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US79892806P 2006-05-09 2006-05-09
US84850606P 2006-09-29 2006-09-29
US84850706P 2006-09-29 2006-09-29
US84850406P 2006-09-29 2006-09-29
US84850506P 2006-09-29 2006-09-29
US84821306P 2006-09-29 2006-09-29
PCT/US2007/011228 WO2008024141A2 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Publications (2)

Publication Number Publication Date
EP2015803A2 EP2015803A2 (fr) 2009-01-21
EP2015803A4 true EP2015803A4 (fr) 2009-05-06

Family

ID=39107260

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07835752A Withdrawn EP2015803A4 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Country Status (4)

Country Link
EP (1) EP2015803A4 (fr)
AU (1) AU2007288442A1 (fr)
CA (1) CA2650197A1 (fr)
WO (1) WO2008024141A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
AU2008241470B2 (en) 2007-04-16 2013-11-07 Corium Pharma Solutions, Inc. Solvent-cast microneedle arrays containing active
MX349292B (es) * 2008-11-18 2017-07-21 3M Innovative Properties Co Disposición de microagujas huecas y método.
AU2015271878B2 (en) * 2010-04-28 2017-05-11 Sorrento Therapeutics, Inc. Device for delivery of rheumatoid arthritis medication
WO2012046149A1 (fr) 2010-04-28 2012-04-12 Kimberly-Clark Worldwide, Inc. Procédé d'augmentation de la perméabilité d'une barrière épithéliale
KR101790815B1 (ko) * 2010-04-28 2017-10-26 킴벌리-클라크 월드와이드, 인크. 세포성 상호작용이 향상된 나노패턴화 의료 기구
US9522263B2 (en) 2010-04-28 2016-12-20 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
MX336139B (es) 2010-04-28 2016-01-08 Kimberly Clark Co Dispositivos medicos para la entrega de arn de interferencia corta.
ES2719595T3 (es) 2010-05-04 2019-07-11 Corium Int Inc Método y dispositivo para la administración transdérmica de la hormona paratiroidea usando una matriz de microproyección
WO2012130193A1 (fr) * 2011-03-31 2012-10-04 Zentiva, K.S. Complexes solubles non covalents de tériparatide contenant des polysaccharides et forme pharmaceutique de tériparatide pour administration orale
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
PL3542851T3 (pl) 2011-10-27 2022-04-25 Sorrento Therapeutics, Inc. Wszczepialne urządzenia do dostarczania środków biologicznie czynnych
AU2012328037B2 (en) 2011-10-27 2017-11-02 Vivasor, Inc. Transdermal delivery of high viscosity bioactive agents
WO2013086731A1 (fr) * 2011-12-16 2013-06-20 London Metropolitan University (Lmu) Appareil d'amenée
BR102012031954A2 (pt) * 2012-12-14 2015-01-20 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras com subtância ativa para aplicação cosmética de liberação controlada obtidas por eletrofiação e processo
BR102012031955A2 (pt) * 2012-12-14 2014-10-07 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras contendo substância ativa com liberação controlada para aplicação odontológica e processo
RU2698095C2 (ru) 2012-12-21 2019-08-22 Кориум Интернэшнл, Инк. Микроматрица для доставки терапевтического средства и способы использования
AU2014249471B2 (en) 2013-03-12 2019-01-24 Corium Pharma Solutions, Inc. Microprojection applicators
JP6689187B2 (ja) 2013-03-15 2020-04-28 コリウム， インコーポレイテッド 複数の衝突微小突起アプリケータおよび使用方法
JP2016512754A (ja) 2013-03-15 2016-05-09 コリウム インターナショナル， インコーポレイテッド 治療剤の送達のためのマイクロアレイ、使用方法および製造方法
JP6700170B2 (ja) 2013-03-15 2020-05-27 コリウム， インコーポレイテッド 治療剤の送達のためのマイクロアレイおよび使用の方法
AU2014237279B2 (en) 2013-03-15 2018-11-22 Corium Pharma Solutions, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
KR101527469B1 (ko) * 2013-11-04 2015-06-11 연세대학교 산학협력단 다양한 삼차원 구조를 갖는 다공성 섬유 마이크로 구조체의 제조방법
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
JP7162014B2 (ja) 2017-01-23 2022-10-27 アフリックス セラピューティクス アー／エス 電界紡糸繊維に基づく２層生成物の製作方法
DE102017112573A1 (de) * 2017-06-07 2018-12-13 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation von Glukagon-ähnlichen-Peptid Analoga
WO2021072113A1 (fr) * 2019-10-08 2021-04-15 Afyx Therapeutics A/S Compositions destinée à l'administration de protéines
KR102405984B1 (ko) * 2020-02-07 2022-06-08 카오카부시키가이샤 피부 외용 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
WO2006027780A2 (fr) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
WO2006027780A2 (fr) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Also Published As

Publication number Publication date
AU2007288442A1 (en) 2008-02-28
EP2015803A2 (fr) 2009-01-21
WO2008024141A8 (fr) 2009-07-09
CA2650197A1 (fr) 2008-02-28
WO2008024141A3 (fr) 2008-04-24
WO2008024141A2 (fr) 2008-02-28

Similar Documents

Publication Publication Date Title
EP2015803A4 (fr) Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances
EP1905065A4 (fr) Systeme et procede pour une configuration cylindre a cylindre
GB0607851D0 (en) Particulate matter generator
IL220270A0 (en) Polymyxin derivatives and uses thereof
ZA200902823B (en) Oligoribonucleotides and uses thereof
EP1999615A4 (fr) Système de stockage d'égal à égal efficace et fiable
EP2015856A4 (fr) Dispositifs d'interaction musicale
IL194751A0 (en) Drugs and uses
EP2084745A4 (fr) Dispositif et son procédé de fabrication
EP2036034A4 (fr) Système de conformité de version
HK1139986A1 (en) Pharmaceutical manufacturing methods
EP2049032A4 (fr) Impacteur amélioré
EP2074676A4 (fr) Système de mise en forme de faisceau dépendant de l'inclinaison
TWI366746B (en) Lithography system and lithography method using the same
EP2064403A4 (fr) Dispositif de verrouillage, appareil de verrouillage et système de verrouillage
EP2158052A4 (fr) Espace annulaire perméable
PL2106258T3 (pl) Ibuprofen przeciwko kaszlowi
PL1917655T3 (pl) System z korpusem świecącym oraz korpus świecący do systemu z korpusem świecącym
ZA200904125B (en) A stable glutaraldehyde complex
EP2015621A4 (fr) Plaque, dispositif de mise en forme utilisant la plaque, et methode de mise en forme
PL386667A1 (pl) Aktywna technika zbierania danych
EG25404A (en) Temporary bridge.
GB0616171D0 (en) Improved incineration
GB0605172D0 (en) Sudoku addict
AU2006902798A0 (en) Rocker device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081025

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20090408

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090708